Zhang Jian-Guo, Wang Yan-Wei, Li Lan, Wen Biao
Department of Gastroenterology, The First Affiliated Hospital of Chengdu Medical College, Chengdu 610000, Sichuan Province, China.
World J Hepatol. 2025 May 27;17(5):104688. doi: 10.4254/wjh.v17.i5.104688.
Recently, Jayabalan published an important study. The authors defined the liver outcome score as a novel biomarker for predicting liver-related mortality in patients with autoimmune hepatitis-primary biliary cholangitis overlap syndrome. After thoroughly reviewing their work, we offer insights that primarily relate to their study design to enhance the medical community's understanding of this complex disease.
最近,贾亚巴兰发表了一项重要研究。作者将肝脏结局评分定义为预测自身免疫性肝炎-原发性胆汁性胆管炎重叠综合征患者肝脏相关死亡率的一种新型生物标志物。在全面审视他们的工作后,我们提供了主要与他们的研究设计相关的见解,以增进医学界对这种复杂疾病的理解。